Document Actions
News & Press
Up one levelSite News
DENTAL MANAGEMENT COMPANY PAYS $24 MILLION TO RESOLVE FRAUD ALLEGATIONS
The National Association of Medicaid Fraud Control Units (NAMFCU) announced on January 20 that twenty-two other states and the federal government to have settled allegations against FORBA Holdings, LLC., a dental management company that provided management services to Small Smiles dental clinics nationwide.
OMNICARE AND OTHER COMPANIES TO PAY $98 MILLION TO SETTLE ALLEGATIONS OF FRAUD
The National Association of Medicaid Fraud Control Units announced on November 4 that an agreement has been reached with Omnicare, Inc. and IVAX Pharmaceuticals, Inc. to settle allegations that the companies engaged in unlawful kickback schemes that defrauded federal and state healthcare programs.
FOUR PHARMACEUTICAL COMPANIES AGREE TO PAY $124 MILLION FOR ALLEGED SUBMISSION OF FALSE CLAIMS TO MEDICAID
The National Association of Medicaid Fraud Control Units announced on October 19, 2009 that an agreement has been reached with four pharmaceutical companies that will pay a total of $124 million to resolve claims that they violated the federal False Claims Act by failing to pay appropriate rebates for drugs that were paid for by Medicaid.
NAMFCU 2009 Annual Training Program
NAMFCU held its 2009 Annual Training Program in Louisville, Kentucky, hosted by the Kentucky Medicaid Fraud Control Unit, September 13 – September 17. Kentucky Attorney General Jack Conway made opening remarks and a press release prepared by his office appears below. After the Attorney General’s remarks, Assistant Attorney General Tony West, who heads the U.S. Department of Justice’s Civil Division, gave the keynote address on federal-state cooperation in health care fraud cases. His speech is linked to the right of the press release.
Remarks of Assistant Attorney General Tony West
Below is the speech made by Assistant Attorney General Tony West at the NAMFCU 2009 Annual Training Program in Louisville, Kentucky.
Pfizer Inc to Pay $2.3 Billion in Historic Settlement
The National Association of Medicaid Fraud Control Units announced on September 2, 2009 that an agreement has been reached with Pfizer Inc to settle civil and criminal allegations that Pfizer and its subsidiaries paid kickbacks and engaged in off-labeling marketing campaigns that improperly promoted numerous drugs that Pfizer manufactures. This is the largest settlement in history in a health care fraud matter. Pfizer will pay the states and the federal government a total of $1 billion in civil damages and penalties to compensate Medicaid, Medicare, and various federal healthcare programs for harm suffered as a result of its conduct.
THE NATIONAL ASSOCIATION OF MEDICAID FRAUD CONTROL UNITS ANNOUNCES A $12.4 MILLION DOLLAR SETTLEMENT WITH QUEST DIAGNOSTICS
The National Association of Medicaid Fraud Control Units announced on August 6, 2009 that a $12.4 million national Medicaid civil settlement with Quest Diagnostics Incorporated (Quest) and its former subsidiary Nichols Institute Diagnostics (NID), to resolve claims concerning the accuracy of various NID diagnostic tests manufactured, marketed and sold to laboratories during 2000-2006, which in turn were used to perform testing which was billed to and paid for by the state Medicaid Programs.
Aventis Pharmaceutical, Inc. resolves allegations for misreporting Best Prices for Azmacort, Nasacort and Nasacort AQ
The National Association of Medicaid Fraud Control Units has announced on June 5 that a proposed $95.5 million global settlement with Aventis Pharmaceutical, Inc, a wholly-owned subsidiary of sanofi-aventis U.S., LLC. The settlement agreement will resolve allegations that between 1995 and 2000, Aventis and its corporate predecessors knowingly misreported best prices for the steroid-based anti-inflammatory nasal sprays Azmacort, Nasacort and Nasacort AQ.
ELI LILLY TO PAY MORE THAN $1.4 BILLION FOR OFF- LABEL DRUG MARKETING
The National Association of Medicaid Fraud Control Units announced on January 15, 2009 that it has joined with the federal government and reached an agreement in principle with Eli Lilly and Company, to settle allegations it engaged in an off-label marketing campaign that improperly promoted the anti-psychotic drug, Zyprexa.
Bristol-Myers Squibb Settles For $389 Million to Resolve Medicaid Pharmaceutical Pricing and Marketing Allegations
The National Association of Medicaid Fraud Control Units Announces a $35 million dollar settlement with Walgreens
Patient Safety and Abuse Prevention Act of 2007
Forty-one Attorneys General and three state authorities that house Medicaid Fraud Control Units signed a letter to members of Congress in support of the Patient Safety and Abuse Prevention Act of 2007 (S. 1577, H.R. 3078), which would establish a system of screening and national criminal history background checks for prospective workers in nursing homes and other long-term care programs.
The National Association of Medicaid Fraud Control Units (NAMFCU) announces $9.8 million settlement with Medicis.
Aventis Pharmaceuticals Inc. Held Accountable for Defrauding State Medicaid Programs In A Drug Pricing Scheme
The National Association of Medicaid Fraud Control Units (“NAMFCU”) Enters into Settlement with Purdue Pharmaceuticals
The National Association of Medicaid Fraud Control Units (“NAMFCU”) announced on October 3, 2001, that it has reached an agreement in principle with TAP Pharmaceutical Products, Inc. (“TAP”)
The National Association of Medicaid Fraud Control Units (NAMFCU) announced on April 16 the largest Medicaid fraud settlement ever involving pharmaceutical manufacturers.